Welcome to Drug and Alcohol Treatment
| ||
Drug Treatment Bipolar Depression Article
This is a selection made from among articles on Drug Treatment Bipolar Depression. For a permanent link to this article, or to bookmark it for future reading, click here.
The Psychiatric Aspect of Drug Addiction
from:There is a reason people become addicted to drugs. The psychiatric aspect of addiction to drugs can be very powerful. Our minds are very complex and the thoughts we have can become rulers in our lives.
Because we are these complex beings with the capabilities of thinking and reasoning, we often discount the mind as just a small part of who we are. Nothing could be further from the truth. The psychiatric implications of drug use are ever prevalent and can wreak havoc in the lives of someone with an addiction to drugs.
What exactly are we talking about? The psychiatric aspects of the mind and how our mind can control our lives is something mental professionals have known about for awhile now. It’s time you learned yourself.
For example, if you are the child of an addict – whether it be a pot-head parent or an alcoholic parent, your mind begins to justify your own marijuana use or alcohol use as being alright. After all, if your parents are doing it, it can’t be all bad for you – right? Well, that’s what your mindset becomes.
Drugs also have an effect on the brain. It’s a proven, scientific fact that addiction is a brain problem and the American Psychiatric Association has proven this. When you start using drugs, your brain gets used to having that drug around. When it’s not present, your mind starts “talking” to you and you believe what it says – that you must have that drug to function.
What can you do to try and beat the psychiatric implications of drug addiction? The best answer to that question is to get some help. That means talking to a counselor or health professional about your addiction and asking ways that you can overcome your addiction.
There are many programs available to people who are dealing with drug addiction. They treat both the mind and the body, because you will be going through some withdrawal symptoms when you decide to stop doing drugs. With professional help, you will be able to successfully conquer the hold that drug addiction has on you, your life, and your mind.
You don’t necessarily have to enter a rehab facility, but when you contact a psychiatrist or psychologist seeking help for your addictions, you will find that beating that demon will become much, much easier. Rehab facilities can be expensive and so can psychiatrists, but once you realize that you will need outside help to beat your addiction, you will be better able to get on your way to a drug-free life.
Drug Treatment Bipolar Depression Specific links
Drug Treatment Bipolar Depression News
Positive results from Dainippon Sumitomo Pharma's LATUDA trials for bipolar I depression
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression (PREVAIL 1 and PREVAIL 2; PRogram to EValuate the Antidepressant Impact of Lurasidone).
Read more...Dainippon Sumitomo Pharma Reports that Latuda® (lurasidone HCl) Met Primary and Key Secondary Endpoints in Two Phase ...
Dainippon Sumitomo Pharma Co., Ltd. announced today results from two Phase 3 clinical trials designed to evaluate the efficacy and safety of LATUDA as adjunctive therapy and monotherapy, respectively, in patients with bipolar I depression .
Read more...Despite Atlantic City attack, schizophrenia needn't lead to violence
People with schizophrenia, the mental illness that afflicted a woman who allegedly killed two Canadian tourists in Atlantic City on Monday, are generally not violent, experts say, but the risk that they will be rises when they stop taking medications and start taking illicit drugs. A history of violent behavior and exposure to violence as a child are also red flags.It is difficult to get people ...
Read more...Corcept Therapeutics Announces First Quarter Results and Corporate and Development Update
MENLO PARK, CA-- - Corcept Therapeutics Incorporated , a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic and psychiatric ...
Read more...Program teaches care for relatives with mental illness
For more information about Family- to-Family education class to be held in Staunton, contact Elizabeth Mawyer, president of Augusta We Care, the local chapter of the National Alliance for Mental Illness, at 332-8595.
Read more..."Rehab With Dr. Drew" Returns To VH1 To Directly Help Young Adults With Their Addiction Issues
LOS ANGELES, May 1, 2012 /PRNewswire/ -- VH1 and Dr. Drew has started production today on a sixth installment of " Rehab with Dr. Drew " to directly address alcohol and drug addiction among young ...
Read more...Bias Found in Mental Health Drug Research Presented at Major Psychiatric Meeting
Patient care nationwide may be affected when research on medications contain only 'good news' - especially when the research is industry-funded.
Read more...Antidepressants and children
A prescription for antidepressant drugs is often given to alleviate migraines, anxiety, depression or chronic pain. When the patient is a small child, however, there's added concern about the possibility of these drugs causing children to have suicidal thoughts.
Read more...Pfizer Announces New Long-Term Relapse Prevention Data For PRISTIQ® (desvenlafaxine) 50 mg/day For The Treatment Of ...
Pfizer Inc. announced new data presented at the 165th Annual Meeting of the American Psychiatric Association in Philadelphia on PRISTIQ® Extended Release Tablets 50 mg/day for the treatment of major depressive disorder in adults,1 including a long-term relapse prevention study.
Read more...Results from a Phase 3 Study of Once-Monthly Aripiprazole Intramuscular (IM) Depot Formulation for the Maintenance ...
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S today announced results from a Phase 3 clinical trial evaluating the efficacy, safety and tolerability of once-monthly aripiprazole intramuscular depot formulation for the maintenance treatment of adults with schizophrenia.
Read more...